Gene therapy for the treatment of oral squamous cell carcinoma.
about
Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapyInterventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapyInterventions for the treatment of oral and oropharyngeal cancers: immunotherapy/biotherapyInterventions for the treatment of oral and oropharyngeal cancers: surgical treatmentPrimary microcephaly gene MCPH1 shows signatures of tumor suppressors and is regulated by miR-27a in oral squamous cell carcinoma.Strategies for targeting protein therapeutics to selected tissues and cells.RNAi targeting CXCR4 inhibits tumor growth through inducing cell cycle arrest and apoptosis.The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines.Association between IL-10 polymorphisms (-1082A/G, -592A/C and -819T/C) and oral cancer risk.Gene therapy: the end of the rainbow?Oncolytic activity of Sindbis virus in human oral squamous carcinoma cellsThe current state of head and neck cancer gene therapy.Emergence of cancer stem cells in head and neck squamous cell carcinoma: A therapeutic insight with literature reviewDelivery systems for gene therapy.Gene therapy in oral cancer: a review.An overview of gene therapy in head and neck cancer.Oncoapoptotic markers in oral cancer: prognostics and therapeutic perspective.Knockdown of Myosin 6 inhibits proliferation of oral squamous cell carcinoma cells.Inhibitory Effects of AVEMAR on Proliferation and Metastasis of Oral Cancer Cells.Cinnamomum cassia essential oil and its major constituent cinnamaldehyde induced cell cycle arrest and apoptosis in human oral squamous cell carcinoma HSC-3 cells.Correlation between the levels of survivin and survivin promoter-driven gene expression in cancer and non-cancer cells.Serum decreases the size of Metafectene-and Genejammer-DNA complexes but does not affect significantly their transfection activity in SCCVII murine squamous cell carcinoma cells.Gingival changes in wistar rats after oral treatment with 4-nitroquinoline 1-oxide.Alkylation-induced genotoxicity as a predictor of DNA repair deficiency following experimental oral carcinogenesis.Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.Lipid composition of cationic nanoliposomes implicate on transfection efficiency.Abnormal expression of bcl-2 and bax in rat tongue mucosa during the development of squamous cell carcinoma induced by 4-nitroquinoline 1-oxide.Oxidative DNA damage is a preliminary step during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide.Interventions for the treatment of oral cancerOverexpression of MARCKS indicates a poor prognosis of oral squamous cell carcinoma
P2860
Q24187274-3E979EA6-3AF6-4361-8523-A26E4F441F8EQ24201366-AD85B791-5FC6-4C8D-AC4C-AA1B6FDF432DQ24202546-CB190BF6-124E-45A8-A17E-04DA257A471AQ24242951-0E4132D6-4A1B-4C42-8097-805ADC661B3EQ34614246-2011D38D-AB63-4CDB-8D11-8251285F7EE4Q35609785-824A5C3A-FD88-4CA3-AB36-5017DF855FC7Q35750000-3639C78F-E50D-43C8-B673-812E1A0D4C94Q36069729-364B012C-83F3-4522-9EA0-05DB06AAC1F4Q36182974-AA8CBB05-9EEF-42E0-B221-8BDB8C05DC99Q37158534-444B8BD4-42B5-4CC3-95D2-885C71B1992CQ37330702-E12C00C4-E91C-433E-90E3-B8259B61E632Q37595513-D09CFB7F-621F-476B-BD4A-EE226F46E08BQ38054095-1647609D-6ECE-4A1A-9C40-482148F7AAB2Q38125444-709256B3-C1AE-4DCF-B1E6-899A4D3E5B21Q38125693-9440C010-6DA5-4103-A711-087D44AE7B12Q38171470-4872CD56-6197-4415-AA63-359DD598FE8EQ38212609-41B11F0F-4D3F-4C62-926A-367C439597E9Q38736867-8967B706-3BB7-498E-93AA-6FC92AF380E5Q38783910-FECE9F41-BDC4-4AB9-92C6-FD3AA084F31EQ38790798-8ADE26ED-63F5-47F4-BC20-4415D3BC3CF8Q39931913-4FB77FB0-560F-4316-9C33-9CCB395781DAQ40254555-ECE6AE5B-2B44-4E4C-8E73-ED40914AC319Q42027094-830CF643-D9FE-41DC-A6E6-08B8AC7CE699Q42501289-361CA5FE-5335-4EEA-A5FE-4A4C21FF002AQ42946802-BC4C82C6-B92B-459E-9F26-BDCF1F506CC2Q44787204-C672F3FE-0BE9-4CB1-9B3B-69AB882667B0Q46821457-4B08EB9A-D4BD-4C03-B0C5-BE089D879B3AQ53288826-FF8DE491-6127-4577-96A2-F70210F9690FQ57168439-463AF9D8-1C55-4F09-B776-4459735B8E69Q58772590-409145BE-A3D0-4BED-8D7A-2EB97A7E3559
P2860
Gene therapy for the treatment of oral squamous cell carcinoma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Gene therapy for the treatment of oral squamous cell carcinoma.
@ast
Gene therapy for the treatment of oral squamous cell carcinoma.
@en
type
label
Gene therapy for the treatment of oral squamous cell carcinoma.
@ast
Gene therapy for the treatment of oral squamous cell carcinoma.
@en
prefLabel
Gene therapy for the treatment of oral squamous cell carcinoma.
@ast
Gene therapy for the treatment of oral squamous cell carcinoma.
@en
P2860
P1476
Gene therapy for the treatment of oral squamous cell carcinoma.
@en
P2860
P356
10.1177/154405910308200104
P407
P577
2003-01-01T00:00:00Z